GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASLAN Pharmaceuticals Ltd (NAS:ASLN) » Definitions » PB Ratio

ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) PB Ratio : (As of Apr. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is ASLAN Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), ASLAN Pharmaceuticals's share price is $0.4126. ASLAN Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.76. Hence, ASLAN Pharmaceuticals's PB Ratio of today is .

The historical rank and industry rank for ASLAN Pharmaceuticals's PB Ratio or its related term are showing as below:

During the past 10 years, ASLAN Pharmaceuticals's highest PB Ratio was 9.55. The lowest was 1.09. And the median was 4.03.

ASLN's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.385
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, ASLAN Pharmaceuticals's average Book Value Per Share Growth Rate was -225.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.40% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of ASLAN Pharmaceuticals was 15.40% per year. The lowest was -4.90% per year. And the median was 5.25% per year.

Back to Basics: PB Ratio


ASLAN Pharmaceuticals PB Ratio Historical Data

The historical data trend for ASLAN Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASLAN Pharmaceuticals PB Ratio Chart

ASLAN Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.36 3.00 -

ASLAN Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.76 9.55 - -

Competitive Comparison of ASLAN Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, ASLAN Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASLAN Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASLAN Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where ASLAN Pharmaceuticals's PB Ratio falls into.



ASLAN Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ASLAN Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.4126/-0.755
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


ASLAN Pharmaceuticals  (NAS:ASLN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


ASLAN Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of ASLAN Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
3 Temasek Avenue, Level 18, Centennial Tower, Singapore, SGP, 039190
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Headlines

From GuruFocus